July 12, 2014 5:04 PM ET

Biotechnology

Company Overview of VISCUM AG

Company Overview

VISCUM AG, a biopharmaceutical company, engages in the research and development of drugs from natural sources. Its products include traditional herbal medicines, such as plant extract preparations; active molecules, such as hormones, antibiotics, and immunosuppressive drugs; and antineoplastic agents for the treatment of cancer. The company was founded in 1999 and is based in Bergisch-Gladbach, Germany. VISCUM AG was formerly a subsidiary of Biotechnology Research and Information Network AG.

Technologiepark

Haus 8

Friedrich-Ebert-Strasse

Bergisch-Gladbach,  51429

Germany

Founded in 1999

Phone:

49 2204 84 49 00

Fax:

49 2204 84 49 10

Key Executives for VISCUM AG

Chief Executive Officer and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
BC&D Concepts GmbH Europe
SpectraMab GmbH Europe
AdnaGen AG Europe
LipoNova AG Europe
AnDiaTec GmbH & Co. KG Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VISCUM AG, please visit www.viscum-ag.de/english/viscum2.htm. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.